Literature DB >> 22834783

Genetics of primary intraocular tumors.

Nisha Nagarkatti-Gude1, Yujuan Wang, Mohammad Javed Ali, Santosh G Honavar, Martine J Jager, Chi-Chao Chan.   

Abstract

Primary intraocular neoplasms are tumors that originate within the eye. The most common malignant primary intraocular tumor in adults is uveal melanoma and the second is primary intraocular lymphoma or vitreoretinal (intraocular) lymphoma. The most common malignant intraocular tumor in children is retinoblastoma. Genetics plays a vital role in the diagnosis and detection of ocular tumors. In uveal melanoma, monosomy 3 is the most common genetic alteration and somatic mutations of BAP1, a tumor suppressor gene, have been reported in nearly 50% of primary uveal melanomas. The retinoblastoma gene RB1 is the prototype tumor suppressor gene-mutations in RB1 alleles lead to inactivated RB protein and the development of retinoblastoma. Immunoglobulin heavy chain (IgH) or T-cell receptor (TCR) gene rearrangement is observed in B-cell or T-cell primary vitreoretinal lymphoma, respectively. Other factors related to the genetics of these three common malignancies in the eye are discussed and reviewed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22834783      PMCID: PMC3436423          DOI: 10.3109/09273948.2012.702843

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  131 in total

Review 1.  Eye cancer: unique insights into oncogenesis: the Cogan Lecture.

Authors:  J William Harbour
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

2.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

Authors:  D E Jensen; M Proctor; S T Marquis; H P Gardner; S I Ha; L A Chodosh; A M Ishov; N Tommerup; H Vissing; Y Sekido; J Minna; A Borodovsky; D C Schultz; K D Wilkinson; G G Maul; N Barlev; S L Berger; G C Prendergast; F J Rauscher
Journal:  Oncogene       Date:  1998-03-05       Impact factor: 9.867

3.  Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16).

Authors:  A D Singh; C M Croce; K K Wary; J A Shields; L A Donoso; C L Shields; K Huebner; M Ohta
Journal:  Ophthalmic Genet       Date:  1996-03       Impact factor: 1.803

4.  Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.

Authors:  Mohamed H Abdel-Rahman; Robert Pilarski; James B Massengill; Benjamin N Christopher; Ryan Noss; Frederick H Davidorf
Journal:  Melanoma Res       Date:  2011-06       Impact factor: 3.599

5.  Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas.

Authors:  I S Lossos; A A Alizadeh; M B Eisen; W C Chan; P O Brown; D Botstein; L M Staudt; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

6.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.

Authors:  Ryan T Phan; Riccardo Dalla-Favera
Journal:  Nature       Date:  2004-12-02       Impact factor: 49.962

7.  RB1 gene mutations in retinoblastoma and its clinical correlation.

Authors:  Mohammad Javed Ali; Vidya Latha Parsam; Santosh G Honavar; Chitra Kannabiran; Geeta K Vemuganti; Vijay Anand P Reddy
Journal:  Saudi J Ophthalmol       Date:  2010-02-06

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 9.  HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.

Authors:  Rosa Mendez; Natalia Aptsiauri; Ana Del Campo; Isabel Maleno; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido; Angel Garcia-Lora
Journal:  Cancer Immunol Immunother       Date:  2009-04-02       Impact factor: 6.968

10.  Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.

Authors:  N Soufir; B Bressac-de Paillerets; L Desjardins; C Lévy; J Bombled; I Gorin; P Schlienger; D Stoppa-Lyonnet
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

View more
  4 in total

1.  Matrine inhibits the growth of retinoblastoma cells (SO-Rb50) by decreasing proliferation and inducing apoptosis in a mitochondrial pathway.

Authors:  Qingliang Shao; Xiaxia Zhao; Li Yao
Journal:  Mol Biol Rep       Date:  2014-02-11       Impact factor: 2.316

2.  Inhibitory effect of bufalin on retinoblastoma cells (HXO-RB44) via the independent mitochondrial and death receptor pathway.

Authors:  Qingfeng Meng; Yan Zhao; LiXin An; Xia Li; Ping Liu
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 3.  Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives.

Authors:  Alessandra Loda; Marta Turati; Francesco Semeraro; Sara Rezzola; Roberto Ronca
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

4.  Vitreoretinal lymphomas misdiagnosed as uveitis: Lessons learned from a case series.

Authors:  Luca Cimino; Marco Coassin; Chi-Chao Chan; Sylvia Marchi; Matteo Belpoliti; Andrea Fanti; Alfonso Iovieno; Luigi Fontana
Journal:  Indian J Ophthalmol       Date:  2016-05       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.